You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ANRO Exercise Disclosure
Smith Nicholas Conrad · SEC Form 4 · Filed Oct 5, 2026
Exercise
Calculated transaction value
$127.6K
Smith Nicholas Conrad President And CFO
ANRO
Transaction date
Oct 2, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 3 days later
ANRO daily price context
Close on/before transaction
$24.8
Oct 2, 2026
First close after public filing
$23.69
Oct 6, 2026
30-day return after filing
-1.65%
Through Nov 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 55,000 shares @ $2.32
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002009130-26-000006
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$127.6K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Alto Neuroscience, Inc. ANRO Current | Exercise | Oct 2, 2026 | $127.6K |
| Alto Neuroscience, Inc. ANRO | Exercise | Oct 2, 2026 | $0 |